Latest News
Latest News
News & Press
Business Achievements
- NanoNeurosciences Reaches a Landmark FDA Milestone, Accelerating the Path to the Clinic23 July 2026, 3:54 pm
NanoNeurosciences is proud to announce the completion of its Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead candidate, NNS-01, a landmark achievement...
- Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential7 July 2026, 4:00 pm
C1 Monoclonal Antibody Progress for RSV and MalariaFollowing Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla. — July 7, 2026 — Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a...
- FORGE Coalition Launches to Position Tampa Bay as Southeast Hub for Radiopharmaceutical Innovation,28 May 2026, 3:01 pm
FORGE Coalition Launches to Position Tampa Bay as Southeast Hub for Radiopharmaceutical Innovation, Training and ProductionMay 26, 2026TAMPA, Fla. (May 27, 2026) — A new regional coalition, the Florida Oncology...
- Omeza announces closing of $8.5 Million Series A financing21 April 2026, 3:25 pm
Omeza announces closing of $8.5 Million Series A financing co-led by Astanor and BluKap Ventures, with participation from Catalyst Investments Round positions Omeza to accelerate clinical development and scale...
- Defence Therapeutics Announces Closing Of Private Placement Of Units For Gross Proceeds Of$9,595,00031 March 2026, 9:51 pm
March 9, 2026Montreal, QC, Canada, March 9, 2026 — Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a publicly traded biotechnology and precision intracellular drug-delivery company,...
- Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch17 February 2026, 8:32 pm
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human AlbuminJUPITER, Fla. and ANKENY, Iowa, Feb. 17, 2026 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”, “we”,...
- Israeli medtech firm Ossio opens Palmetto HQ, plans 100 jobs5 February 2026, 1:36 pm
The new Palmetto headquarters combines manufacturing and surgeon training with plans to add about 100 jobs.Chuck Merlis February 4, 2026OSSIO Inc. opened its U.S. headquarters Tuesday in the City of...
- BioStem Technologies Advances Entry into the Acute Wound Care Market26 January 2026, 4:29 pm
BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care BusinessJanuary 21, 2026 17:30 ET | Source: BioStem Technologies, Inc.Accelerates expansion...
- BioFL Announces Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the SE Chapter22 December 2025, 9:50 pm
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is excited to announce the appointment of Anthony Japour, CEO of iTolerance, Inc. ("iTolerance"), as Southeast...
- BioFlorida Fuels Innovation: Awards $90,000 in Annual Pitch Competition16 December 2025, 3:04 pm
BIOPITCH, featured at the annual Florida Innovation Conference, highlights the state's most promising life sciences venturesORLANDO, Fla., Dec. 15, 2025 /PRNewswire/ -- BioFlorida's annual BIOPITCH competition took center stage, highlighting...

